487 related articles for article (PubMed ID: 17259382)
1. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
Russo LM; del Re E; Brown D; Lin HY
Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
[TBL] [Abstract][Full Text] [Related]
2. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
3. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
4. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
[TBL] [Abstract][Full Text] [Related]
5. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
[TBL] [Abstract][Full Text] [Related]
6. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
7. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
[TBL] [Abstract][Full Text] [Related]
8. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
9. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Horm Metab Res; 2001 Nov; 33(11):664-9. PubMed ID: 11733869
[TBL] [Abstract][Full Text] [Related]
10. [Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-beta1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy].
Liu S; Tang LQ; Chen LM; Chen XQ; Zhang ST; Wei Y
Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):68-72. PubMed ID: 18338624
[TBL] [Abstract][Full Text] [Related]
11. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
13. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
14. Pyridoxal phosphate prevents progression of diabetic nephropathy.
Nakamura S; Li H; Adijiang A; Pischetsrieder M; Niwa T
Nephrol Dial Transplant; 2007 Aug; 22(8):2165-74. PubMed ID: 17449494
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Lin Y; Sun Z
J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
[TBL] [Abstract][Full Text] [Related]
16. Soluble transforming growth factor beta type II receptor attenuates TGF-beta1 activity in human colorectal cancer LoVo cells.
Zhou R; Xiong B; Song H; Liu S; Wang X
Oncol Rep; 2008 Dec; 20(6):1449-56. PubMed ID: 19020727
[TBL] [Abstract][Full Text] [Related]
17. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
18. [Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy].
Tang L; Lv F; Liu S; Zhang S
Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3494-7. PubMed ID: 22368864
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
Mou S; Wang Q; Shi B; Gu L; Ni Z
Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
[TBL] [Abstract][Full Text] [Related]
20. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
